Research Paper Volume 12, Issue 24 pp 25304—25318

Identification of novel prognostic biomarkers in renal cell carcinoma

class="figure-viewer-img"

Figure 6. OS of the signature with multiple genes in RCC. (A) Patients were classified by risk score and their survival status; (B) OS of the signature of multiple genes in this model, which indicated that patients in the low-risk group had a more favorable OS than those in the high-risk group. (C) ROC curves suggested that the accuracy of this model was 76.6%, 71.6% and 72.9% at 1, 3 and 5 years, respectively.